Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 121,220 | reported | 06 Jan 2026 | tx 11+7,016,600−1,268,580 |
| Protara Therapeutics, Inc. | 20,662 | reported | 15 Jul 2022 | tx 6+269,381−5,081 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | SALE | Cartesian Therapeutics, Inc. | 10,591 | 6.82 USD | |
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 37,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 109,000 | 0.00 USD | deriv |
| 06 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 4,028 | 16.83 USD | |
| 03 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 3,961 | 16.72 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 22,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 64,600 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 2,424,000 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 3,110,000 | 0.00 USD | deriv |
| 13 Nov 2023 | OTHER | Cartesian Therapeutics, Inc. | 1,250,000 | 0.79 USD | deriv |
| 28 Nov 2022 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 1,250,000 | 0.00 USD | deriv |
| 15 Jul 2022 | TAX_WITHHOLDING | Protara Therapeutics, Inc. | 5,081 | 3.13 USD | |
| 03 Jan 2022 | GRANT_AWARD | Protara Therapeutics, Inc. | 14,100 | 0.00 USD | |
| 03 Jan 2022 | GRANT_AWARD | Protara Therapeutics, Inc. | 84,800 | 0.00 USD | deriv |
| 19 Jan 2021 | GRANT_AWARD | Protara Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 22 Sept 2020 | PURCHASE | Protara Therapeutics, Inc. | 1,481 | 16.91 USD | |
| 11 Feb 2020 | GRANT_AWARD | Protara Therapeutics, Inc. | 94,000 | 0.00 USD | deriv |